FDA panel gives OK to Glaxo, Ligand drug

Comment icon 0 Comments
Surprise! A Food and Drug Administration advisory panel is backing approval for a blood-clotting drug being developed by GlaxoSmithKline and... Read more

Business execs warm to Phila.'s business climate

Comment icon 0 Comments
“It’s Always Sunny in Philadelphia” is not just the name of a cable-TV show. It describes the positive thinking that seems... Read more

Redlasso will keep feeding bloggers, defying broadcasters' wishes

Comment icon 0 Comments
Redlasso Inc. will not acquiesce to several broadcasters’ request that it cease and desist in providing their video content over its... Read more

Cephalon, Endo and peers want to be heard

Comment icon 0 Comments
When it comes to lobbying and the pharmaceutical industry, apparently you can never have too many voices. The Center for Responsive Politics... Read more

Cephalon, Endo see regulatory issues that unite mid-cap firms

Comment icon 0 Comments
How many voices does an industry need? When it comes to the pharmaceutical industry, apparently you can never have too many. A couple of... Read more

Mace's former CEO whistles his defense

Comment icon 0 Comments
Can the CEO of a publicly held company be a whistleblower? Well, that’s what Louis D. Paolino Jr. seems to be claiming in a letter filed... Read more

Mace's ex-CEO unloads in self-defense

Comment icon 0 Comments
More details have emerged about the rift between Mace Security International Inc. and its CEO that led to his ouster last week for misconduct... Read more

Hendricks to leave Unisys for EDS

Comment icon 0 Comments
Unisys Corp. is losing one of its senior executives. Randy J. Hendricks, president of Unisys' Global Industries business unit, will step down... Read more